Aadi Bioscience Inc

NASDAQ:AADI  
13.26
-0.01 (-0.08%)
6:49:01 PM EDT: $13.31 +0.05 (+0.38%)
Officer Changes, Earnings Announcements

Aadi Bioscience Announces Financial Results For Third Quarter

Published: 11/09/2022 15:54 GMT
Aadi Bioscience Inc (AADI) - Aadi Bioscience Announces Financial Results for the Third Quarter of 2022 and Provides Corporate Update.
Q3 Sales Rose 24 Percent to $4.2 Million.
Qtrly Loss per Share $0.68.
Cash, Cash Equivalents and Short-term Investments As of September 30, 2022 Were $183.0 Million.
Appointment of Neil Desai to Executive Chairman and Transition of Brendan Delaney to CEO Effective January 1, 2023.
Precision 1 Trial On-track With Preliminary Data Expected in First Half of 2023.
Q3 Earnings per Share View $-0.74 -- Refinitiv Ibes Data (analyst estimates).completed $72.5 Million Pipe Financing Extending Cash Runway Into 2025.
Revenue is expected to be $4.65 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $4.55 Million
Next Quarter EPS Guidance is expected to be -$0.70

More details on our Analysts Page.